Charles E. Stacey
Amministratore Delegato presso Cerecin, Inc.
Profilo
Charles E.
Stacey is currently the President, Chief Executive Officer & Director at Cerecin, Inc. He has been in this position since 2015.
In terms of education, Dr. Stacey has a graduate degree from Imperial College London, an undergraduate degree from University College London, an MBA from London Business School, and a doctorate from King's College London.
Posizioni attive di Charles E. Stacey
| Società | Posizione | Inizio |
|---|---|---|
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Amministratore Delegato | 02/06/2015 |
Formazione di Charles E. Stacey
| London Business School | Masters Business Admin |
| Imperial College London | Graduate Degree |
| King's College London | Doctorate Degree |
| University College London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Cerecin, Inc.
Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Health Technology |
- Borsa valori
- Insiders
- Charles E. Stacey
